Table 5.
Acute adverse events recorded during concurrent high-dose intensity-modulated radiation therapy and docetaxel-based chemotherapy: dermatology/skin
| Grade | Rash/dermatitis | Highest | |
|---|---|---|---|
| Cohort 1 |
1 |
2 |
2 |
| 2 |
0 |
0 |
|
| 3 |
0 |
0 |
|
| Cohort 2 |
1 |
1 |
1 |
| 2 |
0 |
0 |
|
| 3 | 0 | 0 |